| Medical and Health Sciences | Lifetime | 136 | AU 6 | 99.99 |
| Medical and Health Sciences | 2021-2025 | 650 | AU 25 | 99.86 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 12 | AU 1 | 99.96 |
| Cardiology and Cardiovascular Medicine | Lifetime | 33 | AU 1 | 99.97 |
| Complementary and Alternative Medicine | Lifetime | 103 | AU 5 | 99.53 |
| Critical Care and Intensive Care Medicine | Lifetime | 269 | AU 16 | 94.64 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 90 | AU 4 | 99.61 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 65 | AU 6 | 98.80 |
| Critical Care and Intensive Care Medicine | 2021-2025 | 176 | AU 14 | 74.38 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 1 | AU 1 | 99.82 |
| Cardiac Imaging and Diagnostics | Lifetime | 11 | AU 1 | 99.97 |
| Cardiovascular Function and Risk Factors | Lifetime | 12 | AU 1 | 99.97 |
| Ultrasound in Clinical Applications | Lifetime | 4 | AU 1 | 99.66 |
| Cardiac Valve Diseases and Treatments | Lifetime | 38 | AU 1 | 99.89 |
| Cardiovascular Effects of Exercise | Lifetime | 15 | AU 1 | 99.81 |
| Cardiovascular Disease and Adiposity | Lifetime | 28 | AU 1 | 99.79 |
| Advanced MRI Techniques and Applications | Lifetime | 96 | AU 1 | 99.60 |
| Cardiovascular Health and Disease Prevention | Lifetime | 68 | AU 3 | 99.51 |
| Cardiac pacing and defibrillation studies | Lifetime | 87 | AU 4 | 99.65 |
| Heart Failure Treatment and Management | Lifetime | 106 | AU 3 | 99.59 |
| Cardiac Structural Anomalies and Repair | Lifetime | 141 | AU 3 | 99.52 |
| Hemodynamic Monitoring and Therapy | Lifetime | 96 | AU 3 | 99.19 |
| Cardiac, Anesthesia and Surgical Outcomes | Lifetime | 316 | AU 12 | 99.24 |
| Cardiovascular and exercise physiology | Lifetime | 114 | AU 13 | 99.36 |
| Blood Pressure and Hypertension Studies | Lifetime | 243 | AU 16 | 99.20 |
| Pulmonary Hypertension Research and Treatments | Lifetime | 225 | AU 6 | 98.75 |
| Cardiomyopathy and Myosin Studies | Lifetime | 249 | AU 9 | 98.51 |
| Cardiac electrophysiology and arrhythmias | Lifetime | 506 | AU 8 | 98.73 |
| Pericarditis and Cardiac Tamponade | Lifetime | 62 | AU 1 | 98.05 |
| Heart Rate Variability and Autonomic Control | Lifetime | 483 | AU 27 | 98.37 |
| Advanced X-ray and CT Imaging | Lifetime | 359 | AU 8 | 98.16 |
| Acute Myocardial Infarction Research | Lifetime | 377 | AU 7 | 98.82 |
| Cardiac Arrhythmias and Treatments | Lifetime | 756 | AU 15 | 98.18 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 864 | AU 20 | 98.04 |
| Cardiac Health and Mental Health | Lifetime | 406 | AU 31 | 97.26 |
| Ultrasound and Hyperthermia Applications | Lifetime | 358 | AU 3 | 96.54 |
| Infective Endocarditis Diagnosis and Management | Lifetime | 755 | AU 19 | 97.30 |
| Polymer Nanocomposite Synthesis and Irradiation | Lifetime | 952 | AU 17 | 87.78 |
| Takotsubo Cardiomyopathy and Associated Phenomena | Lifetime | 407 | AU 19 | 85.32 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 35 | AU 1 | 99.56 |
| Chemotherapy-induced cardiotoxicity and mitigation | 2021-2025 | 8 | AU 1 | 98.96 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 86 | AU 2 | 99.43 |
| Heart Failure Treatment and Management | 2021-2025 | 168 | AU 3 | 98.03 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 130 | AU 4 | 94.24 |
| Cardiac Valve Diseases and Treatments | 2021-2025 | 387 | AU 5 | 97.39 |
| Ultrasound in Clinical Applications | 2021-2025 | 212 | AU 4 | 91.12 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 534 | AU 24 | 90.60 |
| Cancer Treatment and Pharmacology | 2021-2025 | 679 | AU 17 | 87.88 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 987 | AU 47 | 87.74 |
| Cardiovascular Health and Disease Prevention | 2021-2025 | 665 | AU 21 | 85.31 |
| Cardiac Health and Mental Health | 2021-2025 | 803 | AU 57 | 83.18 |
| Cardiovascular Effects of Exercise | 2021-2025 | 960 | AU 48 | 81.86 |
